A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

Details 詳細情報について

• CRID

  1363670320915894272

• DOI

  10.1016/j.leukres.2018.10.002

• ISSN

  01452126

• Web Site

  https://api.elsevier.com/content/article/PII:S0145212618302480?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0145212618302480?httpAccept=text/plain

• Data Source

  • Crossref